Evidence map›Paper›PMID 42918903›Full record

ArticleNature chemical biology2026

Chemogenetic activation of mitochondria counteracts the Warburg effect in tumor cells.

Dina Y Bass, Ekaterina S Potekhina, Alexander V Ivanenko, Aleksandr A Moshchenko, Dmitry A Korzhenevskiy, Alexey M Nesterenko, Evgeny K Shevchenko, Anastasia E Karnaeva, Natalia F Zakirova, Alexander V Ivanov and 12 more

Abstract read
PubMed Publisher
In one paragraph

Article in Nature chemical biology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

22 authors.

Dina Y Bass *Federal Center of Brain Research and Neurotechnologies, Federal Medical Biological Agency, Moscow, Russia.
Ekaterina S Potekhina *Federal Center of Brain Research and Neurotechnologies, Federal Medical Biological Agency, Moscow, Russia.
Alexander V IvanenkoFederal Center of Brain Research and Neurotechnologies, Federal Medical Biological Agency, Moscow, Russia.
Aleksandr A MoshchenkoFederal Center of Brain Research and Neurotechnologies, Federal Medical Biological Agency, Moscow, Russia.ORCID http://orcid.org/0000-0003-4833-4686
Dmitry A KorzhenevskiyFederal Center of Brain Research and Neurotechnologies, Federal Medical Biological Agency, Moscow, Russia.
Alexey M NesterenkoFederal Center of Brain Research and Neurotechnologies, Federal Medical Biological Agency, Moscow, Russia.ORCID http://orcid.org/0000-0003-1592-257X
Evgeny K ShevchenkoFederal Center of Brain Research and Neurotechnologies, Federal Medical Biological Agency, Moscow, Russia.
Anastasia E KarnaevaFrumkin Institute Of Physical Chemistry And Electrochemistry, Russian Academy Of Sciences, Moscow, Russia.ORCID http://orcid.org/0000-0002-3692-8607
Natalia F ZakirovaCenter for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.
Alexander V IvanovCenter for Precision Genome Editing and Genetic Technologies for Biomedicine, Engelhardt Institute of Molecular Biology, Russian Academy of Sciences, Moscow, Russia.ORCID http://orcid.org/0000-0002-5659-9679
Liubov E ShimolinaInstitute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, Nizhny Novgorod, Russia.
Marina V ShirmanovaInstitute of Experimental Oncology and Biomedical Technologies, Privolzhsky Research Medical University, Nizhny Novgorod, Russia.
Olga V LyangFederal Center of Brain Research and Neurotechnologies, Federal Medical Biological Agency, Moscow, Russia.
Olga I PatsapFederal Center of Brain Research and Neurotechnologies, Federal Medical Biological Agency, Moscow, Russia.
Olga M KudryashovaFederal Center of Brain Research and Neurotechnologies, Federal Medical Biological Agency, Moscow, Russia.ORCID http://orcid.org/0000-0003-3320-7764
Guzel R GazizovaRegulatory Genomics Research Center, Institute of Fundamental Medicine and Biology, Kazan Federal University, Kazan, Russia.
Elena I ShagimardanovaLIFT, Life Improvement by Future Technologies (LIFT) Center, Moscow, Russia.
Sofia S MariasinaDepartment of Chemistry, Lomonosov Moscow State University, Moscow, Russia.ORCID http://orcid.org/0000-0002-9190-1298
Vasiliy A IvlevResearch and Educational Resource Center "Pharmacy", RUDN University, Moscow, Russia.ORCID http://orcid.org/0000-0001-9664-9506
Ivan BogeskiMolecular Physiology Division, Institute of Cardiovascular Physiology, University Medical Center, Georg-August University Göttingen, Göttingen, Germany.ORCID http://orcid.org/0000-0001-9879-7174
Oleg A GusevFederal Center of Brain Research and Neurotechnologies, Federal Medical Biological Agency, Moscow, Russia.ORCID http://orcid.org/0000-0002-6203-9758
Vsevolod V BelousovFederal Center of Brain Research and Neurotechnologies, Federal Medical Biological Agency, Moscow, Russia. belousov@fccps.ru.ORCID http://orcid.org/0000-0001-6637-8098

Funding

Russian Science Foundation (RSF) 23-75-30023
6 · The paper itself

Abstract

Upregulation of glycolysis and downregulation of mitochondrial oxidative phosphorylation, termed as the Warburg effect, is characteristic of tumor cells. Restriction of pyruvate flux into the mitochondrial matrix is one of the major mechanisms underlying this phenomenon. Warburg metabolism is beneficial for rapidly proliferating cells; however, the metabolic consequences of activation of mitochondrial respiration in such cells remain unclear. Here we created a chemogenetic instrument, Grubraw, that generates pyruvate from ᴅ-alanine directly in the mitochondrial matrix, bypassing restricted pyruvate influx. In cancer cells, Grubraw-produced mitochondrial pyruvate increased oxidative metabolism. Chemogenetic activation of mitochondria slowed the growth rate of human melanoma xenografts. Moreover, activation of cancer cell mitochondria suppressed the transcription of genes that control cell-cycle progression, cell proliferation and DNA replication. Surprisingly, we found that cancer cells with Warburg metabolism control carbon flux by disposing of excess mitochondrial pyruvate produced by Grubraw and exporting it out of the cell.

Identifiers

PMID42918903

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.